1. Home
  2. EQS vs BNGO Comparison

EQS vs BNGO Comparison

Compare EQS & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equus Total Return Inc.

EQS

Equus Total Return Inc.

N/A

Current Price

$1.45

Market Cap

15.9M

Sector

Finance

ML Signal

N/A

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.31

Market Cap

12.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQS
BNGO
Founded
1991
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
12.8M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
EQS
BNGO
Price
$1.45
$1.31
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
7.3K
161.6K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
94.50
EPS
N/A
N/A
Revenue
N/A
$12,000,735.00
Revenue This Year
N/A
$14.99
Revenue Next Year
N/A
$34.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$1.10
$1.06
52 Week High
$2.49
$5.50

Technical Indicators

Market Signals
Indicator
EQS
BNGO
Relative Strength Index (RSI) 52.09 62.02
Support Level $1.29 $1.10
Resistance Level $1.50 $1.31
Average True Range (ATR) 0.09 0.06
MACD 0.01 0.01
Stochastic Oscillator 60.56 72.92

Price Performance

Historical Comparison
EQS
BNGO

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. The company invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: